Clinical Significance of Antibodies to DFS70 in Immunoinflammatory Rheumatic Diseases

被引：0
|
作者：
Panafidina, T. A. [1 ]
Verizhnikova, Zh. G. [1 ]
Avdeeva, A. S. [1 ]
Popkova, T. V. [1 ]
Nasonov, E. L. [1 ,2 ]
机构：
[1] Nasonova Res Inst Rheumatol, Moscow, Russia
[2] Sechenov First Moscow State Med Univ, Sechenov Univ, Minist Hlth Russian Federat, Moscow, Russia
来源：
DOKLADY BIOCHEMISTRY AND BIOPHYSICS | 2024年 / 517卷 / 01期
关键词：
immunoinflammatory rheumatic diseases; anti-DFS70; antinuclear antibodies; indirect immunofluorescence assay on HEp-2 cells; DENSE FINE SPECKLES; CLASSIFICATION CRITERIA; ANTI-DFS70; ANTIBODIES; AMERICAN-COLLEGE; HEALTHY-INDIVIDUALS; AUTOANTIBODIES; PREVALENCE; CONSENSUS; SURVIVAL;
D O I：
10.1134/S1607672924700911
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
The relevance of the problem of immunoinflammatory rheumatic diseases (IIRD) for modern medicine is determined by their high prevalence in the population, the difficulty of early diagnosis, the rapid development of disability and poor life prognosis. Recent data on the significance of anti-DFS70 have opened up new possibilities for optimizing the step-by-step diagnosis of IIRD. The detection of these antibodies can help in the interpretation of a positive result for antinuclear antibodies (ANA) by indirect immunofluorescence assay on HEp-2 cells (IIFA-HEp-2) in the absence of autoantibodies specific for IIRD. Detection of anti-DFS70 in antinuclear factor (ANF) seropositive patients without clinical and/or serological markers characteristic of a certain disease from the IIRD group can be considered as a potential marker that excludes this group of diseases.
引用
收藏
页码：207 / 213
页数：7
相关论文
共 50 条
  • [31] Anti-dense fine speckled 70 (DFS70) autoantibodies: correlates and increasing prevalence in the United States
    Dinse, Gregg E.
    Zheng, Bing
    Co, Caroll A.
    Parks, Christine G.
    Weinberg, Clarice R.
    Miller, Frederick W.
    Chan, Edward K. L.
    FRONTIERS IN IMMUNOLOGY, 2023, 14
  • [32] Clinical Phenotypes of Patients with Anti-DFS70/LEDGF Antibodies in a Routine ANA Referral Cohort
    Miyara, Makoto
    Albesa, Roger
    Charuel, Jean-Luc
    El Amri, Mohamed
    Fritzler, Marvin J.
    Ghillani-Dalbin, Pascale
    Amoura, Zahir
    Musset, Lucile
    Mahler, Michael
    CLINICAL & DEVELOPMENTAL IMMUNOLOGY, 2013,
  • [33] Janus kinase inhibitors in immunoinflammatory rheumatic diseases
    Hacohob, E. A.
    Nasonov, Evgeny L.
    TERAPEVTICHESKII ARKHIV, 2022, 94 (05) : 605 - 609
  • [34] Prevalence of anti-dense fine speckled 70 antibodies in healthy individuals and patients with antinuclear antibody-associated autoimmune rheumatic diseases in Japan
    Hayashi, Nobuhide
    Uto, Kenichi
    Imanishi, Akiko
    Sugiyama, Daisuke
    Morinobu, Akio
    Saegusa, Jun
    MEDICINE, 2021, 100 (09) : E24556
  • [35] Investigation of anti-DFS70 antibody in patients with systemic autoimmune rheumatic diseases
    Peker, Bilal Olcay
    Sener, Asli Gamze
    Tarhan, Emine Figen
    Kaya, Selcuk
    CLINICAL RHEUMATOLOGY, 2019, 38 (12) : 3627 - 3633
  • [36] ANTI-DFS70: ARE THEY HELPFUL WHEN ASSESSING FOR SYSTEMIC AUTOIMMUNE RHEUMATIC DISEASES?
    Galarza, D.
    Carrion, I.
    Veloza, C.
    Perello, H. Sirera
    Salman-Monte, T.
    Pros, A.
    Villegas, E.
    Eguia, J.
    Perez, C.
    Monfort, J.
    ANNALS OF THE RHEUMATIC DISEASES, 2023, 82 : 2080 - 2081
  • [37] Anti-DFS70 Antibodies: A Useful Biomarker in a Pediatric Case With Suspected Autoimmune Disease
    Fabris, Martina
    Zago, Silvia
    Tosolini, Raffaello
    Melli, Paola
    Bizzaro, Nicola
    Tonutti, Elio
    PEDIATRICS, 2014, 134 (06) : E1706 - E1708
  • [38] Investigation of the Clinical Significance of Anti-Dense Fine Speckled 70 (anti-DFS70) Autoantibody and Determination of Accompanying Pathologies
    Duran, Alev Cetin
    Barut, Kayra
    Duran, Ali
    Daglar, Duygu Eren
    MIKROBIYOLOJI BULTENI, 2021, 55 (03): : 415 - 425
  • [39] Measurement of anti-DFS70 antibodies in patients with ANA-associated autoimmune rheumatic diseases suspicion is cost-effective
    Gundin, Simon
    Irure-Ventura, Juan
    Asensio, Esther
    Ramos, David
    Mahler, Michael
    Martinez-Taboada, Victor
    Lopez-Hoyos, Marcos
    AUTOIMMUNITY HIGHLIGHTS, 2016, 7 (01)
  • [40] Clinical value of anti-DFS70 antibodies in a cohort of patients undergoing routine antinuclear antibodies testing
    Yumuk, Zeki
    Demir, Melike
    JOURNAL OF IMMUNOLOGICAL METHODS, 2020, 480
12345